GERON CORP Revenues
GERON CORP (GERN) reported Revenues of $191.00 thousand for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-03-16
- GERON CORP revenues for the quarter ending 2017-12-31 was $191.00K, a 103.19% increase year-over-year.
- GERON CORP revenues for the quarter ending 2017-09-30 was $163.00K, a 96.81% decline year-over-year.
- GERON CORP revenues for the quarter ending 2017-06-30 was $174.00K, a 17.54% decline year-over-year.
- GERON CORP revenues for the quarter ending 2017-03-31 was $537.00K, a 28.30% decline year-over-year.
- GERON CORP revenues for fiscal 2017 was $1.06M, a 82.72% decline from fiscal 2016.
- GERON CORP revenues for fiscal 2016 was $6.16M, a 83.06% decline from fiscal 2015.
- GERON CORP revenues for fiscal 2015 was $36.37M, a 3054.47% increase from fiscal 2014.
- GERON CORP revenues for fiscal 2014 was $1.15M, a 10.13% decline from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2017-12-31 | $191.00K 10-K · filed 2018-03-16 | $354.00K derived: sum of 2 quarters · filed 2018-03-16 | $528.00K derived: sum of 3 quarters · filed 2018-03-16 | $1.06M 10-K · filed 2018-03-16 |
| 2017-09-30 | $163.00K 10-K · filed 2018-03-16 | $337.00K derived: sum of 2 quarters · filed 2018-03-16 | $874.00K derived: sum of 3 quarters · filed 2018-03-16 | $968.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | $174.00K 10-K · filed 2018-03-16 | $711.00K derived: sum of 2 quarters · filed 2018-03-16 | $805.00K derived: sum of 3 quarters · filed 2018-03-16 | $5.91M derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | $537.00K 10-K · filed 2018-03-16 | $631.00K derived: sum of 2 quarters · filed 2018-03-16 | $5.74M derived: sum of 3 quarters · filed 2018-03-16 | $5.95M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-12-31 | $94.00K 10-K · filed 2018-03-16 | $5.20M derived: sum of 2 quarters · filed 2018-03-16 | $5.41M derived: sum of 3 quarters · filed 2018-03-16 | $6.16M 10-K · filed 2018-03-16 |
| 2016-09-30 | $5.11M 10-K · filed 2018-03-16 | $5.32M derived: sum of 2 quarters · filed 2018-03-16 | $6.07M 10-Q · filed 2016-11-03 | $6.29M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $211.00K 10-K · filed 2018-03-16 | $960.00K 10-Q · filed 2016-08-03 | $1.18M derived: sum of 3 quarters · filed 2018-03-16 | $36.54M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $749.00K 10-K · filed 2018-03-16 | $969.00K derived: sum of 2 quarters · filed 2018-03-16 | $36.33M derived: sum of 3 quarters · filed 2018-03-16 | $36.58M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $220.00K 10-K · filed 2017-03-01 | $35.58M derived: sum of 2 quarters · filed 2017-03-01 | $35.83M derived: sum of 3 quarters · filed 2017-03-01 | $36.37M 10-K · filed 2018-03-16 |
| 2015-09-30 | $35.36M 10-K · filed 2017-03-01 | $35.61M derived: sum of 2 quarters · filed 2017-03-01 | $36.15M 10-Q · filed 2016-11-03 | $36.33M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $251.00K 10-K · filed 2017-03-01 | $788.00K 10-Q · filed 2016-08-03 | $966.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.13M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $537.00K 10-K · filed 2017-03-01 | $715.00K derived: sum of 2 quarters · filed 2017-03-01 | $875.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.22M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $178.00K 10-K · filed 2016-03-10 | $338.00K derived: sum of 2 quarters · filed 2016-03-10 | $679.00K derived: sum of 3 quarters · filed 2016-03-10 | $1.15M 10-K · filed 2017-03-01 |
| 2014-09-30 | $160.00K 10-K · filed 2016-03-10 | $501.00K derived: sum of 2 quarters · filed 2016-03-10 | $975.00K 10-Q · filed 2015-11-05 | $1.20M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $341.00K 10-K · filed 2016-03-10 | $815.00K derived: sum of 2 quarters · filed 2016-03-10 | $1.04M derived: sum of 3 quarters · filed 2016-03-10 | $1.22M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $474.00K 10-K · filed 2016-03-10 | $699.00K derived: sum of 2 quarters · filed 2016-03-10 | $880.00K derived: sum of 3 quarters · filed 2016-03-10 | $992.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $225.00K 10-K · filed 2015-03-11 | $406.00K derived: sum of 2 quarters · filed 2015-03-11 | $518.00K derived: sum of 3 quarters · filed 2015-03-11 | $1.28M 10-K · filed 2016-03-10 |
| 2013-09-30 | $181.00K 10-K · filed 2015-03-11 | $293.00K derived: sum of 2 quarters · filed 2015-03-11 | $1.06M derived: sum of 3 quarters · filed 2015-03-11 | $1.75M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-06-30 | $112.00K 10-K · filed 2015-03-11 | $877.00K derived: sum of 2 quarters · filed 2015-03-11 | $1.57M derived: sum of 3 quarters · filed 2015-03-11 | $2.20M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-03-31 | $765.00K 10-K · filed 2015-03-11 | $1.45M derived: sum of 2 quarters · filed 2015-03-11 | $2.09M derived: sum of 3 quarters · filed 2015-03-11 | $2.22M derived: sum of 4 quarters · filed 2015-03-11 |
| 2012-12-31 | $689.00K 10-K · filed 2014-03-17 | $1.32M derived: sum of 2 quarters · filed 2014-03-17 | $1.46M derived: sum of 3 quarters · filed 2014-03-17 | $2.71M 10-K · filed 2014-03-17 |
| 2012-09-30 | $636.00K 10-K · filed 2014-03-17 | $766.00K derived: sum of 2 quarters · filed 2014-03-17 | $2.02M 10-Q · filed 2012-11-02 | $2.27M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $130.00K 10-K · filed 2014-03-17 | $1.38M 10-Q · filed 2012-08-03 | $1.64M derived: sum of 3 quarters · filed 2014-03-17 | $1.85M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $1.25M 10-K · filed 2014-03-17 | $1.50M derived: sum of 2 quarters · filed 2014-03-17 | $1.73M derived: sum of 3 quarters · filed 2014-03-17 | $2.19M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $251.00K 10-K · filed 2013-03-15 | $471.00K derived: sum of 2 quarters · filed 2013-03-15 | $933.00K derived: sum of 3 quarters · filed 2013-03-15 | $2.44M 10-K · filed 2014-03-17 |
| 2011-09-30 | $220.00K 10-K · filed 2013-03-15 | $682.00K derived: sum of 2 quarters · filed 2013-03-15 | $2.19M 10-Q · filed 2012-11-02 | $3.29M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $462.00K 10-K · filed 2013-03-15 | $1.97M 10-Q · filed 2012-08-03 | $3.06M derived: sum of 3 quarters · filed 2013-03-15 | $3.61M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $1.50M 10-K · filed 2013-03-15 | $2.60M derived: sum of 2 quarters · filed 2013-03-15 | $3.15M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.64M derived: sum of 2 quarters · filed 2013-03-15 | $3.56M 10-K · filed 2013-03-15 | |
| 2010-09-30 | $546.00K 10-Q · filed 2011-11-03 | $2.46M 10-Q · filed 2011-11-03 | ||
| 2009-12-31 | $1.73M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |